A report published in the August 26, 2018 edition of the New England Journal of Medicine indicates that the drug Xarelto may offer no benefit in preventing venous thromboembolism events among patients who are already hospitalized. Xarelto (rivaroxaban) is a newer generation of anticoagulant medications... Read More

Xarelto might not be more effective than aspirin when it comes to stroke prevention, and it may carry a higher risk of bleeding. That’s according to a study recently published by Canadian researchers in the New England Journal of Medicine on May 16, 2018. The... Read More

Earlier this month, a Philadelphia jury ordered drug makers Johnson & Johnson and Bayer to pay $28 million to an Indiana plaintiff in the state’s first Xarelto trial. Jurors concluded that the pharmaceutical giants, which developed the blood thinning medication jointly, failed to adequately warn consumers... Read More

A bellwether trial over the risk of bleeding injury with Xarelto (rivaroxoaban) opened in Philadelphia in early November. The trial will hear a case filed by Lynn Hartman and her spouse, alleging that Xarelto’s side effects cause Ms. Hartman to experience severe internal bleeding. Xarelto... Read More

A widower and his family had been hoping to hold pharmaceutical companies liable for the death of 67-year-old Sharyn M. Orr. The family had filed a lawsuit against Johnson & Johnson and Bayer, alleging that the defendants’ drug Xarelto had caused Orr’s fatal brain hemorrhage.... Read More

In the last week of April, the first bellwether trial involving lawsuits over alleged injuries caused by Xarelto (rivaroxoaban) began with the process of jury selection. The case is one of 16,000 Xarelto lawsuits under a federal multidistrict litigation (MDL) before District Judge Eldon Fallon in the... Read More

In a recently published study, researchers who examined the effects of the three anticoagulants Xarelto, Eliquis, and Pradaxa conclude that Xarelto was associated with more incidents of gastrointestinal bleeding than the other two. All three of the drugs, however, were associated with increased GI bleeding.... Read More

Multidistrict (MDL) litigation established in order to consolidate all federal cases related to Xarelto has now progressed to the point where U.S. District Judge Eldon Fallon has chosen a series of four representative cases which will be heard in early 2017. The purpose of these... Read More